Angiogenesis
Research results from Medical School update understanding of angiogenesis
Published in Women's Health Weekly, August 23rd, 2007
A report, "Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis," is newly published data in Molecular Cancer Therapeutics. According to recent research published in the journal Molecular Cancer Therapeutics, "In view of our previous findings that tumor cell-derived macrophage migration inhibitory factor (MIF) increased macrophage-mediated ovarian cancer cell invasiveness in vitro, we investigated the wider significance of ovarian cancer cell-derived MIF for tumor growth, metastasis, and angiogenesis. We found that MIF is expressed in borderline and malignant ovarian tumors, and active MIF is found in malignant ascitic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Baylor Regional Medical Center
Food Isn’t the Only Thing That Can Expire—Old Makeup Can Harbor Dangerous Bacteria - Bioengineering
Seeking Markers for Menopausal Women at Risk for a Deadly Blood Clot - Breast Implants
Breast Implants Linked to Higher Suicide Risk - Cancer Vaccines
Simple screening technique for cervical cancer can reduce incidence in poor countries - Dartmouth Medical School
Postpartum hospital discharges -- when is the 'right time?' - Depression
Why Women Get More Migraines Than Men - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
